The Durability of Intravesical Oxybutynin Solutions Over Time

Journal of Urology

Volumn 178, Issue 4 SUPPLEMENT, 2007, Pages 1768-1770

  Wan, Julian ^a   Rickman, Cody ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

administration; cholinergic antagonists; intravesical; neurogenic; oxybutynin; pharmacokinetics; urinary bladder

Indexed keywords

ANTIBIOTIC AGENT; DRUG SOLVENT; GENTAMICIN; OXYBUTYNIN; SODIUM CHLORIDE; TAP WATER;

ARTICLE; DRUG DETERMINATION; DRUG SOLUBILITY; DRUG STABILITY; GAS CHROMATOGRAPHY; PILL; PRIORITY JOURNAL; TABLET;

EID: 34548451160     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.181     Document Type: Article

References (13)

1. Mulcahy J.J., James H.E., and McRoberts J.W. Oxybutynin chloride combined with intermittent catheterization in the treatment of myelomeningocele patients. J Urol 118 (1977) 95
2. Diokno A.C., and Lapides J. Oxybutynin: a new drug with analgesic and anticholinergic properties. J Urol 108 (1972) 307
3. Buyse G., Waldeck K., Verpoorten C., Bjork H., Casaer P., and Andersson K.E. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol 160 (1998) 892
4. Massad C.A., Kogan B.A., and Trigo-Rocha F.E. The pharmacokinetics of intravesical and oral oxybutynin chloride. J Urol 148 (1992) 595
5. Madersbacher H., and Knoll M. Intravesical application of oxybutynin: mode of action in controlling detrusor hyperreflexia. Eur Urol 28 (1995) 340
6. Kaplinsky R., Greenfield S.P., Wan J., and Fera M. Expanded follow-up of intravesical oxybutynin chloride use in children with neurogenic bladder. J Urol 156 (1996) 753
7. Connor J.P., Betrus G., Fleming P., Perlmutter A.D., and Reitelman C. Early cystograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients. J Urol 151 (1994) 1045
8. Prasad K.V., and Vaidyanathan S. Intravesical oxybutynin chloride and clean intermittent catheterization in patients with neurogenic vesical dysfunction and decreased bladder capacity. Br J Urol 72 (1993) 719
9. Palmer L.S., Zebold K., Firlit C.F., and Kaplan W.E. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population. J Urol 157 (1997) 638
10. Wan J., Kozminski M., Wang S.C., Faerber G.J., McGuire E.J., Bloom D.A., et al. Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies. Urology 43 (1994) 531
11. O'Neil M.J., Smith A., Heckelman P.E., Obenchain Jr. J.R., Gallipeau J.A.R., and D'Arecca M.A. Oxybutynin, entry 7024. Merck Index (2006), Merck Co, Whitehouse Station, New Jersey 1245
12. Stryer L. Biochemistry. 2nd ed. (1981), WH Freeman and Co, San Francisco 39-40 chapt 2
13. Water Quality Reports. Michigan Department of Utilities and Water 2005.